Yeming Wang
Impact in
- Infectious Diseases top 0.01%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- General Dentistry top 0.05%
Papers in
-
- COVID-19 Clinical Research Studies 24
- SARS-CoV-2 and COVID-19 Research 11
- Epidemiology 31
- Influenza Virus Research Studies 17
- Respiratory viral infections research 5
- Co-authors
- Bin Cao (42 shared papers)Xiaoying Gu (17 shared papers)Guohui Fan (13 shared papers)Jiuyang Xu (11 shared papers)Yuan Wei (2 shared papers)Shengjin Tu (2 shared papers)Xudong Wu (2 shared papers)Fei Zhou (5 shared papers)
- Journals
- Emerging Microbes & Infections (6 papers)The Lancet (5 papers)The Journal of Infectious Diseases (5 papers)The Lancet Respiratory Medicine (4 papers)Clinical Microbiology and Infection (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yeming Wang
110 papers receiving 64.8k citations
Yeming Wang's Hit Papers
Peers
Comparison fields: 5 of 216
- Infectious Diseases 40.6k
- General Dentistry 453
- Modeling and Simulation 3k
- Neurology 3.9k
- Internal Medicine 607
Countries citing papers authored by Yeming Wang
This map shows the geographic impact of Yeming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeming Wang more than expected).
Fields of papers citing papers by Yeming Wang
This network shows the impact of papers produced by Yeming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeming Wang. The network helps show where Yeming Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yeming Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Hit paper breakdown → | 2020 | 35861 |
| 2 | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Hit paper breakdown → | 2020 | 20580 |
| 3 | A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 Hit paper breakdown → | 2020 | 4065 |
| 4 | Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Hit paper breakdown → | 2020 | 2735 |
| 5 | 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study Hit paper breakdown → | 2021 | 816 |
| 6 | Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study Hit paper breakdown → | 2022 | 436 |
| 7 | 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Hit paper breakdown → | 2023 | 264 |
| 8 | 2013 | 144 | |
| 9 | 2007 | 126 | |
| 10 | The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China Hit paper breakdown → | 2024 | 122 |
| 11 | 2019 | 121 | |
| 12 | 2020 | 117 | |
| 13 | 2009 | 97 | |
| 14 | Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials Hit paper breakdown → | 2023 | 84 |
| 15 | 2020 | 72 | |
| 16 | 2020 | 71 | |
| 17 | 2023 | 71 | |
| 18 | Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 Hit paper breakdown → | 2024 | 71 |
| 19 | 2021 | 68 | |
| 20 | 2022 | 64 |
About Yeming Wang
Yeming Wang is a scholar working on Infectious Diseases, Epidemiology, Neurology, Orthopedics and Sports Medicine and Surgery, having authored 118 papers that have together received 67.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (24 papers), Influenza Virus Research Studies (17 papers), Long-Term Effects of COVID-19 (11 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Respiratory viral infections research (5 papers), Bone health and osteoporosis research (4 papers), RNA Research and Splicing (4 papers) and Transplantation: Methods and Outcomes (3 papers). The work is most often cited by research in Infectious Diseases (40.6k citations), General Dentistry (453 citations), Modeling and Simulation (3k citations), Neurology (3.9k citations) and Internal Medicine (607 citations). Yeming Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Bin Cao, Xiaoying Gu, Guohui Fan, Jiuyang Xu, Yuan Wei, Shengjin Tu, Xudong Wu, Fei Zhou, Yi Zhang and Ronghui Du. Their work appears in journals such as Emerging Microbes & Infections, The Lancet, The Journal of Infectious Diseases, The Lancet Respiratory Medicine and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.